Reliever-Triggered Inhaled Glucocorticoid in Black and Latinx Adults with Asthma.
Elliot IsraelJuan-Carlos CardetJennifer K CarrollAnne L FuhlbriggeLilin SheFrank W RockholdNancy E MaherMaureen FaganVictoria E ForthBarbara P YawnPaulina Arias HernandezJean M KruseBrian K ManningJacqueline Rodriguez-LouisJoel B ShieldsBrianna EricsonAlex D Colon-MoyaSuzanne MadisonTamera Coyne-BeasleyGretchen M HammerBarbara M KaplanCynthia S RandJanet RoblesOpal ThompsonMichael E WechslerJuan P WisniveskyM Diane McKeeSunit P JariwalaElina JerschowPaula J BusseDavid C KaelberSylvette NazarioMichelle L HernandezAndrea J ApterKu-Lang ChangVictor Pinto-PlataPaul M StrangesLaura P HurleyJennifer TrevorThomas B CasaleGeoffrey ChuppIsaretta L RileyKartik ShenoyMagdalena PasaricaRafael A Calderon-CandelarioHazel TappAhmet BaydurWilson D PacePublished in: The New England journal of medicine (2022)
Among Black and Latinx adults with moderate-to-severe asthma, provision of an inhaled glucocorticoid and one-time instruction on its use, added to usual care, led to a lower rate of severe asthma exacerbations. (Funded by the Patient-Centered Outcomes Research Institute and others; PREPARE ClinicalTrials.gov number, NCT02995733.).